News Pharma Industry

sun pharma: Sun Pharma has cracked the specialty-drugs code. Can it now raise the bar?

It’s been 10 years since Sun Pharmaceutical Industries forayed into specialty drugs. In 2012, it had acquired a US-based dermatology company, DUSA Pharmaceuticals, to get access to a specialty drug-device combination product, Levulan Kerastick. In those days, Indian companies were doing quite well in the US with their generic-drugs business, launching copy-cat versions of innovative branded drugs. Sun Pharma’s generic-drugs business was going

Source link